Search for a reference number

Responses

ATTR Referrals

Dear Gloucestershire Health and Care NHS Foundation Trust,

For the most recent three complete calendar years (e.g. 2023, 2024 and 2025), please provide:

1. The number of patients your Trust referred onwards with a suspected or confirmed diagnosis of transthyretin amyloidosis (ATTR).

If possible, please break this down by:

• Year
• Referring specialty (e.g. cardiology, neurology, nephrology)

2. For the same period, please specify:

• The external centre(s) to which patients with suspected or confirmed ATTR amyloidosis were referred (e.g. National Amyloidosis Centre, regional amyloidosis hubs, tertiary cardiology centres).

Where available, please include:

• The number of patients referred to each centre per year.

Yours faithfully,

Use of non-visual patient safety aid (NVPSA)

Health, MH Services

Dear Gloucestershire Health and Care NHS Foundation Trust,

I am writing to make a request for information under the Freedom of Information Act 2000 regarding the Trust’s use of specific patient monitoring technology.

1. Does the Trust currently use, or have formal plans to trial or implement, a Non-Visual Patient Safety Aid (NVPSA) – for example, Safehinge Primera’s “Project X”, “Smart Ward” or other radar-based motion tracking – within ward bedrooms, Section 136 suites, and/or seclusion rooms?

2. If the response to the above question is ‘yes’, please provide the following information:

2.1. The number of wards, 136 suites, and seclusion rooms where the technology is deployed (please provide ward names and type of ward).

2.2. The current Policy or Standard Operating Procedure (SOP) governing the use of this technology, including details of your consent process.

2.3. The Data Protection Impact Assessment (DPIA).

2.4. The Equality Impact Assessment (EqIA).

2.5. The Clinical Safety Case Report and Clinical Hazard Log (as required by DCB0129/DCB0160 standards). Please also provide a copy of any entries on the Trust’s Organisational Risk Register that relate to “transferred risks” or residual risks identified during the deployment of this technology.

2.6. The contract start and end dates for the current provision.

2.7. Minutes of meetings where the decision to adopt, trial, continue, expand, or cease the use of the technology was made, including the rationale for the decision.

2.8. Copies of patient-facing information, such as posters, leaflets, or privacy notices provided to service users and carers.

2.9. Copies of all staff training materials or presentation slides relating to the use of NVPSA, including details of the Trust’s competency assurance framework, the mandated frequency of refresher training and the compliance rate (percentage of staff on the relevant wards who have completed training).

3. Please provide all recorded information relating to regulatory compliance, including:

3.1. Any internal audit, gap analysis, or briefing paper that demonstrates how the use of NVPSA technology complies with the Care Quality Commission (CQC) published guide on “Digital contactless patient monitoring technologies in mental health in-patient services”.

3.2. Evidence (e.g. a compliance statement or committee minute) showing how the deployment of this monitoring technology aligns with the NHS England’s “Principles for using digital technologies in mental health inpatient treatment and care”.

If you feel a Section 40 (Personal Information) or Section 43 (Commercial Interests) exemption applies to any part of this request, please provide a redacted version of the documents rather than a blanket refusal, and include the required public interest test for any qualified exemptions.

Yours faithfully,

Maternity Claims

GHNHSFT - Redirect

RE: Request under the Freedom of Information Act (2000)

Dear Information Team

This is an information request regarding compensation paid for maternity claims.

Please include the following information for the following years 2022/23, 2023/24, 2024/25 and 2025/26

• The total value of compensation claims paid in respect of maternity claims, please include a break down by:
o Claimant costs
o The Trust’s legal costs

• Total number of maternity compensation claims made, broken down by:
o Settled with admission of liability
o Settled without admission of liability
o Failed claims

• Total number of maternity claims currently open or in progress

• A breakdown of the reasons for maternity compensation claims and the number of cases that fell into each category.
o (for example Cerebral palsy and other brain injuries to the baby, stillbirth, neonatal death, other significant injury to the baby, maternal death, significant maternal injury, psychological injury etc)

• For each year please provide the largest maternity compensation claim including information on:
o Total damages paid
o The category of the maternal injury

If this is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you have any queries please don’t hesitate to contact me via email or phone and I will be very happy to clarify what I am asking for.

I would prefer a response via email, but if not possible, I will gladly accept letters to the address below.

Please acknowledge this information request as soon as possible.

Kind regards,

Complex Home Care

Health

Under the Freedom of Information Act, I would like to request the following information relating to patients requiring complex home care packages on discharge from hospital.

For clarity, “complex home care” refers to high-acuity packages requiring significant care input (e.g. ventilation, tracheostomy care, enteral feeding, or complex neurological support) that goes beyond basic domiciliary home care assistance.

Failing that definition, please define “complex home care” as any home care package eligible for funding under the NHS Continuing Healthcare (CHC) funding pathway.

Please note I have requested a breakdown of the data by age group. If data cannot be broken down by requested age bands, then please provide total figures across all age groups, adults aged 18+ and children aged 0-17.

If data for the full year 2025/26 is not yet available, then please provide the latest yearly snapshot data for 2025/26.

Where possible, please kindly include responses on the attached spreadsheet.

1. Please provide the name, telephone number and email address of the person responsible for coordinating / liaising discharge from hospital to community health and social care providers.

2. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the total number of bed days lost due to delays in arranging CHC-funded complex home care packages across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

3. Please provide the most recent available snapshot (e.g. March 2026) of the total number of patients currently in hospital who are medically fit for discharge but are awaiting a CHC-funded complex home care package across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

4. If available, please also provide latest equivalent snapshots for prior years (e.g. March 2025, March 2024, March 2023) of the total number of patients currently in hospital who are medically fit for discharge but are awaiting a CHC-funded complex home care package across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

5. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the average time (in days) from being medically fit for discharge to discharge where a CHC-funded complex home care package is required across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

6. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the number of patients who were assessed as requiring complex home care but were discharged to an alternative setting (e.g. residential or nursing care) due to a lack of CHC-funded complex home care packages across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years
Kind regards,

Haemophilia A and B and von Willebrand Patients

Health, Pharmacy

Hi FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information (FOI) Act 2000 I would like to obtain the following information:

In Q1 2026 (January, February, March 2026), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used?

Brand name Number of treated patients Volume used (IUs, mg)
Hemlibra (non-inhibitor patients)
Hemgenix
Altuvoct
Advate
Adynovi
Elocta
Esperoct
NovoEight
ReFacto AF
Nuwiq
Hympavzi
Idelvion
Refixia
Alprolix
BeneFIX
Replenine
Rixubis
Veyvondi
Voncento
Wilate
Willfact

Best wishes,

Net Zero Staff and Consultant Spending

ESR/Workforce, Estates, Finance, Staffing

Dear Sir or Madam,

Under the Freedom of Information Act 2000, please provide the following recorded information.

From the financial year 2024/25, 2023/24, and 2022/23 figures:

1. Climate-related posts

a) The number of posts (headcount, and FTE where recorded) employed by the council with job titles that include any of the following terms:

Climate; Net Zero; Sustainability; Carbon; Emissions; Environmental Sustainability; Climate Change; Climate Action; Climate Policy; Climate Programme; Climate Project; Climate Data; Climate Reporting; Climate Adaptation; Climate Resilience; Energy and Climate; Sustainable Procurement; Green Finance; Green.

2. Cost of those posts

The total employment cost for the posts identified in Question 1, including salary and employer on-costs (e.g. pension and National Insurance), as recorded by the council.

3. External consultants

The total amount paid during the same financial year to external consultants, companies, or contractors where the expenditure is recorded under any cost centre, project code, budget line, or purchase description that includes one or more of the following terms:

This should include, but not be limited to, expenditure coded to professional services, consultancy, advisory services, or specialist support.

If the council does not record expenditure in this way, please provide the closest equivalent recorded information held (for example, totals by relevant cost centre or project).

If any information requested is not held, please state this clearly. If figures are held only in aggregated form, please provide the aggregated figures. Estimates derived from recorded financial information are acceptable.

If complying with this request would exceed the cost limit under Section 12 of the Freedom of Information Act, please provide advice and assistance under Section 16 as to how the request may be refined.

Please provide the information requested above in the following table format, where held:
Financial Year
Job Title
Staff Costs including on-costs (£)
Headcount
Consultant Spend

Yours faithfully,

Temporary and Permanent Agency Labour Spend

ESR/Workforce, What Do They Know

Dear Gloucestershire Health and Care NHS Foundation Trust,

Please could you provide me with the following information:

-Total Non clinical Temporary agency spend from August 2025 to date. ( including admin and clerical roles, ancillary, IT, corporate functions and scientific, technical and clinical coding )

-Agencies used for non clinical recruitment from August 2025 to date.

-Spend broken down by agency from August 2025 to date.

-Please advise if you use an agency for permanent recruitment.

– What framework you use- such as CCS RM6277 , HTE

Yours faithfully,

Workforce Disability Equality Standard

Corporate Governance, HR

Hi Gloucestershire Health and Care NHS team,

I was reading your Annual Equalities Report 2023–24.

You note that the trust publishes annual Workforce Disability Equality Standard action plans, and your disability action plan says the 2021–26 People Strategy agreed actions to improve disability recruitment.

How do you evidence, at the vacancy level before shortlisting, where each role was promoted and what engagement it generated with disabled candidates and communities you are trying to reach?

Disability Network helps employers build that advert stage record at vacancy level. That gives HR clearer evidence if the role is questioned later.

I can send a short overview if useful.

Kind regards,

Incidents of Sexual Violence

Corporate Governance

Dear Sir,

FOI request: Governance related to sexual offending at the trust

1) Please disclose by each of the following years, the total number each year of incidents of sexual violence (including sexual assault and rape) reported by the trust to the Care Quality Commission:

2021/22
2022/23
2023/24
2024/25
2025/26 YTD

2) If the data is held centrally and can be easily processed within FOIA limits, please advise how many of the incidents of sexual violence in the period April 2021 to 2026 YTD were perpetrated against patients.

3) It has been reported by the media that a patient was raped whilst under the trust’s care in the last financial year.

Please confirm if this is the case.

Please advise if and when the CQC was informed of this serious incident

Please advise:

a) if this incident took place on trust premises
b) whether the patient was under inpatient care
c) if the patient was detained under the Mental Health Act

Please advise what review if any has been undertaken by the trust, and what learning and Safeguarding improvements have been made since the incident.

4) Please advise if the trust undertakes any benchmarking to compare its rates of sexual violence against other comparator trusts, the results of any such benchmarking and any action plans arising.

Yours,

Prostate Specific Antigen/suspected prostate cancer referral thresholds

GHNHSFT - Redirect, What Do They Know

Dear Gloucestershire Health and Care NHS Foundation Trust,

1. Do you have a Urology department who see suspected prostate cancer patients referred from the community?

2. What criteria are used to triage (Accept or Reject) referrals from the community, for patients with suspected prostate cancer, including Prostate Specific Antigen (PSA) thresholds and Digital Rectal Examination (DRE) for asymptomatic patients? Please include specific PSA levels used as well as any other criteria

3. What criteria are used to triage (Accept or Reject) referrals from the community, for patients with suspected prostate cancer, including PSA thresholds and DRE for symptomatic patients? Please include specific PSA levels used as well as any other criteria

4. How does your service define symptomatic and asymptomatic for suspected prostate cancer referrals?

5. Do you apply different thresholds or criteria for higher-risk groups (e.g. Black men, men with family history)?

6. For the calendar year 2025:
a. How many patients were referred on the suspected prostate cancer pathway?
b. Of these, how many were classified by the referrer (or by your triage) as asymptomatic?
c. How many were classified as symptomatic?

7. For the same period, how many referred patients had their 2WW referral rejected? Please break this down, if possible, by:
a) Asymptomatic vs symptomatic
b) Rejected primarily due to PSA level below threshold

8. Please provide a copy of your suspected prostate cancer referral form for both asymptomatic and symptomatic patients?

Yours faithfully,

GLP-1 receptor agonists prior to OGD

GHNHSFT - Redirect

Dear Sir/Madam,

I am writing to request information under the Freedom of Information Act 2000 regarding your Trust’s guidance and practice relating to the management of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) prior to upper gastrointestinal endoscopy (oesophago-gastro-duodenoscopy, OGD).

This request forms part of a national study assessing variation in NHS Trust practice. ⸻

Information Requested

1. Guidance Availability

a) Does your Trust have any guidance, protocol, or policy relating to the management of GLP-1 receptor agonists prior to OGD?

b) If yes, please provide:
• A copy of the guidance, or
• A link to where it is publicly available

2. Medication Management

a) What is your Trust’s recommendation regarding oral GLP-1 receptor agonists prior to OGD? (e.g. continue, omit morning dose, withhold for a defined period)

b) What is your Trust’s recommendation regarding injectable GLP-1 receptor agonists prior to OGD?

3. Indication-Specific Guidance

a) Does your Trust differentiate guidance based on indication (e.g. diabetes vs obesity)?

b) If yes, please outline how recommendations differ.

4. Fasting Protocol

a) Does your Trust modify fasting instructions for patients taking GLP-1 receptor agonists prior to OGD?

b) If yes, please provide details of the modified fasting protocol.

5. Operational Impact

a) Has your Trust identified any impact of GLP-1 receptor agonist use on OGD procedures (e.g. cancellations, retained gastric contents, aspiration risk)?

b) If recorded, please provide any available data or summary information.

6. Governance

a) Has the management of GLP-1 receptor agonists in endoscopy been discussed, reviewed, or audited within your Trust?

Format of Response Please provide the information in electronic format where possible. If any part of this request exceeds cost limits, I would be grateful if you could:

• Advise how the request may be refined

or

• Provide the information that falls within the allowable limit

Clarification

This request relates only to adult elective OGD procedures and excludes colonoscopy or other endoscopic procedures unless included within a shared protocol.

Additional Notes

Where exact data is not held, a summary of local practice or clinical guidance is acceptable.

Thank you for your time and assistance.

I look forward to your response within the statutory 20 working days.

Clinical Risk Assessment & Management and or Suicide Prevention

Copy of Trust Policy, Health, MH Services

Hello Gloucestershire Health and Care NHS Trust FOI team,

I am writing to you under the Freedom of Information Act 2000 to request the following information from Gloucestershire Health and Care NHS Trust’s freedom of information department. Please may you provide me with:

1. A copy of your Policie(s)/ procedures, strategies and or any clinical guidance relevant to mental health care pertaining to clinical risk assessment and management and or suicide prevention.
2. Do you use any triage tools, rag rating or scales to stratify clinical risk?
2.1. If Yes, do they inform care in any way including different tiers.
2.2. If Yes please provide a copy.

Please provide the information in the form of word documents or if not possible pdf files.

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you can identify any ways that my request could be refined, I would be grateful for any further advice and assistance.

If you have any queries please don’t hesitate to contact me via email and I will be very happy to clarify what I am asking for and discuss the request, my details are outlined below.

Thank you for your time and I look forward to your response.

Best wishes,

Clinical Waste Management

Estates

Good afternoon
I am a student who is currently researching the clinical waste market in the UK. As part of my research, I have the below questions:
1)Suppliers who applied for inclusion on each Framework / Contract and were successful & not successful at the PQQ & ITT Stages.
2) Actual Spend on this Contract / Framework (and any sub lots), from the start of the Contract to the Current Date.
3) Start Date & Duration of Framework / Contract?
4) Could you please provide a copy of the service / product specification given to all bidders for when this contract was last advertised?
5) Is there an extension clause in the Framework(s) / Contract(s) and, if so, the duration of the extension?
6) Has a decision been made yet on whether the Framework(s) / Contract(s) are being either extended or renewed?
7) Who is the Senior Officer (outside of procurement) responsible for this contract?
8) Who is the Infection Control Lead responsible for the Trust + Contact Information?
9) Who is the Procurement Lead for Clinical Waste contracts for the Trust + Contact Information?
10) Who is the Environmental / Sustainability Lead for the Trust + Contact Information?
11) Who is the Waste Management Lead for the Trust + Contact Information?
12) Who is the Health and Safety Lead for the Trust + Contact Information?
13) Who is the Clinical Waste Incumbent?
14) Does the Trust make use of Reusable or Disposable Sharps Containers?
15) Current waste split between Alternative treatment, Incineration and offensive waste?
Many thanks

Halal Meat – Community Hospitals

Estates

Dear Sir or Madam,

I am writing to make a Freedom of Information Request related to the following hospitals operated by your trust:

Gloucestershire Royal Hospital, Cheltenham General Hospital, Charlton Lane, Honeybourne, Laurel House, Wotton Lawn Hospital, Berkeley House, Cirencester Hospital, Dilke Memorial Hospital, Lydney and District Hospital, North Cotswolds Hospital, Stroud General Hospital, Tewkesbury Community Hospital, Vale Community Hospital, Forest of Dean Community Hospital, The Maxwell Centre, and Fairford Hospital.

1. Do any of the hospitals listed above serve ANY HALAL MEAT?
2. If the answer to (1) is “yes”, is it labelled as such?
3. If the answer to (1) is “yes”, what percentage of meat served is Halal?
4. If the answer to (1) is “yes”, who is your supplier?

Please answer all the above within 28 days.

If you are unable to, or need more time, please inform me within 7 days.

I am assuming there will be no charge: if there is, please let me know within 7 days. I think my questions are straightforward, but if you do not understand the questions, please inform me within 7 days.

Yours faithfully,

Infection Prevention & Control (IPC) – GRHNHSFT

GHNHSFT - Redirect

Dear FOI Team,
Please treat this as a request for information under the Freedom of Information Act 2000.
I would be grateful if you could provide the following information regarding the Infection Prevention & Control (IPC) leadership and IPC nursing team at Gloucestershire Hospitals NHS Foundation Trust, covering:
• Gloucestershire Royal Hospital
• Cheltenham General Hospital
• Any associated services delivered by the Trust
1. IPC Leadership – Names, Roles, and Contact Details
Please provide the name, job title, and NHS email address (where publicly releasable) for the following positions:
• Director of Infection Prevention & Control (DIPC)
• Deputy DIPC
• Lead Nurse for Infection Prevention & Control
• IPC Matron / IPC Manager
• Infection Prevention & Control Doctor (IPCD)
• Any Consultant Microbiologists with designated IPC responsibility
2. IPC Nursing Team
For all IPC nursing staff employed by the Trust, please provide:
• Names
• Job titles and bandings
• NHS email addresses (where publicly releasable)
• The clinical areas or sites they cover
3. IPC Organisational Structure
Please provide:
• The most recent IPC organisational structure chart, including reporting lines
• Any documentation describing how IPC services are structured across the Trust
4. IPC Contact Information
Please provide:
• Any generic IPC team email addresses
• Any team telephone numbers used for clinical enquiries or staff contact
• Any site specific IPC contact details, if applicable
5. Additional IPC Documentation
If available, please provide:
• The most recent IPC Annual Report
• Any IPC governance documents or summaries produced within the last 12 months
If any part of this request is unclear or likely to exceed the appropriate cost limit, please let me know so I may refine it. I am happy to receive the information electronically.

Artificial Intelligence (AI)

Corporate Governance, IT

Dear Sir or Madam,

I am writing to request information under the Freedom of Information Act 2000. This request concerns your organisation’s strategy, governance, and use of artificial intelligence (AI).

For the purposes of this request, artificial intelligence refers to software or systems that perform tasks normally requiring human intelligence, including machine learning, computer vision, natural language processing, and predictive analytics.
I would be grateful if you could provide the answers to the relevant questions by completing the table attached at the end of this request.

1. AI leadership – Does the trust have named leaders for clinical AI tool evaluation and implementation? If so, please provide their names, NHS job titles and NHS email addresses?
2. AI Strategy and Planning – Does the trust have an artificial intelligence (AI) strategy, roadmap, or equivalent strategic document? If yes, please provide a copy or link.
3. AI Policies – Does the trust have approved policies specific to the development, procurement, or use of AI tools? If yes, please provide copies.
4. Governance and Oversight – Does the trust have a dedicated governance committee or formal mechanism reviewing AI initiatives for ethical and safety considerations? If yes, does it include clinical representation?
5. Use of AI in Clinical Care – Is the trust currently using AI tools in clinical care? If yes, does the trust conduct regular audits and use standardised methodologies (e.g. dashboards) to assess financial, clinical, and operational impact?
6. AI Literacy and Training – Does the trust offer AI literacy or skills training for the following staff groups? Please indicate yes/no and provide brief details.

(a) Clinical staff
(b) Technical staff (e.g. clinical scientists)
(c) Operational staff (e.g. secretaries, MDT coordinators and managers).

NHS Trust Name Please confirm the name of the NHS trust

Name(s) of AI evaluation and implementation lead(s) Please add (separate by a “;”/semicolon if more than one lead)

Job title(s) of AI evaluation and implementation lead(s) Please add (separate by a “;”/semicolon if more than one lead)

Email address(es) of AI evaluation and implementation lead(s) Please add (separate by a “;”/semicolon if more than one lead)

Q2: Local AI Strategy Yes/No (delete as appropriate)
Q3: Local AI Policies Yes/No (delete as appropriate)
Q4a: Local governance Yes/No (delete as appropriate)
Q4b: Clinical representation for AI governanceGovernanceClinical Yes/No/Not applicable (delete as appropriate)
Q5: Current AI use Yes/No (delete as appropriate)
Q5b: AI use audit Yes/No/Not applicable (delete as appropriate)
Q5c: AI use impact assessment Yes/No/Not applicable (delete as appropriate)
Q6a: AI training for clinical staff Yes/No (delete as appropriate)
Q6b: AI training for clinical staff Yes/No (delete as appropriate)
Q6c: AI training for operational staff Yes/No (delete as appropriate)

If any part of this request exceeds the cost limit under Section 12 of the Act, please advise which elements could be refined.

If the information is not held, please confirm this.

Thank you very much for your help.

Yours faithfully,

Digital Mental Health

Health, MH Services

In accordance with the freedom of information act, please could you answer the following questions –

– Does the Trust commission or use any digital mental health and wellbeing platforms for its young people?

– Does the Trust mission or provide free access to digital mental health app for its young people?

– Which department, such as Public Health or Children’s Services, manages the commissioning of the digital services in this area?

– When does the current contract for this digital service with the Trust expire, and is it due to be recommissioned?

– Does the Trust provide access to any digital peer support services?

– Does the Trust provide access to any digital mental health services specifically for Autism?

– Does the Trust provide access to any digital mental health services specifically for those who are jobseekers?

Cyber Security Breaches – 2020 to 2026

Dear team,
Under the Freedom of Information Act, I would like to request the following information for each calendar year from 2020 to 2026 inclusive:
1. The number of cyber security breaches that have being identified that were found to be a result of a malicious threat actor (i.e. not accidental data breach)
2. The breakdown in high-level causes of these breaches as identified by cyber security incident response teams (CSIRTs), for example (but not limited to) unpatched software/hardware, lack of multi-factor authentication (MFA), leaked user credentials, lack of in-transit encryption, etc
3. The number of breaches that occurred that were attributed to a previously known vulnerability to the organisations hardware, software, policies, or processes, for example where system was known to be at risk due to being unpatched or out of support, or security controls were recommended but not enforced, and was defined within the resulting incident response report.
4. The estimated combined costs incurred as a result of cyber security breaches defined in request number one in each year.
No specific details are requested in relation to software/hardware utilisation, but rather high-level causes of breaches. I believe the high-level nature of this request does not allow for the use of s.31(1)(a) of the FOIA as this would not be likely to prejudice the security of your systems or data, as these are historical incidents which have since been dealt with. The public interest in understanding breach causes across public sector organisations outweighs the public interest in the exemption.
I would like you to provide the information in Word, Excel, or CSV format.
Please contact me if you need me to clarify my request.

Yours faithfully,

Consultancy spend

Finance

Dear FOI Team,

I am writing to make an open government request for all the information to which I am entitled under the FOI Act 2000.

1. How much did your organisation spend on management consultants in the most recent financial year 2024-25 and if available 2025-26?

2. How much did your organisation spend on management consultants in each of the four categories below in the most recent financial year 2024-25 and if available 2025-26?

A) Strategy and transformation* – encompassing long-term direction-setting, service reconfiguration, operational and programme/project management.

B) Digital and technology* – IT strategy, system implementations (such as EPRs), data analytics, and cyber security.

C) Finance and efficiency – covering cost improvement, financial recovery, procurement, supply chain, and productivity analysis.

D) People and organisation – workforce planning, leadership and culture, HR redesign, governance, and regulatory compliance.

*If the cost of providing the data will exceed FOI limits, then please just address Digital and Technology and Strategy and Transformation categories

3. How much did your organisations spend on interim digital staffing in the most recent financial year 2024-25 and if available 2025-26?

Thank you for your time.

Yours faithfully,

Business Case, Procurement and DPIA Templates and Guidance

Corporate Governance

Dear FOI Team
I would like to request the following information:
1. Your organisation’s internal business case template (blank), and any current internal guides or best practice documents for staff on how to prepare or write a business case. Please include criteria, requirements, or assessment checklists if available.
2. Any internal guides or standing instructions for your budgetary committee(s) on how business cases are to be assessed or reviewed, including any scoring methodologies, criteria, or objective assessment processes.
3. Your current procurement strategy template (blank), or any process documentation relating to the waiver process that may run alongside the business case.
4. Your organisation’s standing financial instructions (SFIs), or equivalent document governing procurement thresholds and authorisation limits.
5. Your Data Protection Impact Assessment (DPIA) template (blank), and any supporting internal guides for staff on how to complete a DPIA.
6. A single example of a business case for a project or solution involving digital technology or a digital supplier, approved by your organisation in the last 18 months. Please redact or remove any information that is commercially sensitive or personal data as required by law. If your organisation has not approved any such business case in this period, please provide an example from the last 18 months for a project or solution involving an external supplier (not involving digital technology). If neither are available, please confirm this.
If any of the above information is not held, or only held for certain departments or areas, please provide what is available and indicate the applicable directorate/area.
Please provide documents in a machine-readable format (such as PDF, DOCX, or XLSX) wherever possible.
If you believe responding to this request in full would exceed the FOIA cost limit, I would be grateful for advice and assistance as to how I might refine or reduce the scope to bring it within limit.
Thank you for your assistance.

Procurement

Contracts, Procurement

Dear FOI Team,

Please provide the following information.

1. Please provide the record from the organisation’s Contract Register or equivalent procurement log entry pertaining to the current contract for the Endpoint Detection and Response (EDR) solution (Include Supplier, Product Name, Start Date, Expiry Date, Annual spend 2025/2026 [£], Additional notes [including any framework used])
 DEFINITION: The practice of securing organisational assets such as laptops, desktops, mobile phones, and servers against malicious activity. It encompasses tools and strategies designed to detect, prevent, and respond to threats directly on the device itself.

2. Please provide the following information for the current maintenance and licensing agreement for the primary Perimeter Firewall/Intrusion Prevention System (IPS) solution (Include Supplier, Product Name, Start Date, Expiry Date, Annual spend 2025/2026 [£], Additional notes [including any framework used])
 DEFINITION: The processes and technologies used to protect the boundaries (the perimeter) of an organisation’s internal network from unauthorised external access. It involves monitoring and controlling incoming and outgoing network traffic.

3. Please provide the following information for the service agreement covering the Cloud Security Posture Management (CSPM) platform or equivalent third-party cloud security monitoring too (Include Supplier, Product Name, Start Date, Expiry Date, Annual spend 2025/2026 [£], Additional notes [including any framework used])
 DEFINITION: The set of security measures designed to protect data, applications, and infrastructure running in cloud environments (e.g., AWS, Azure, GCP). It also includes securing internally and externally facing applications themselves (application security).

4. Please provide the following information for the service agreement covering your Identity & Access Management (IAM) software (Include Supplier, Product Name, Start Date, Expiry Date, Annual spend 2025/2026 [£], Additional notes [including any framework used])
 DEFINITION: A framework of policies and technologies that ensures the right users have the appropriate access to the right resources at the right time. It involves managing digital identities, authentication (verifying identity), and authorisation (granting access).

5. Please provide the record from the organisation’s Contract Register or equivalent procurement log entry pertaining to the current contract for your current Managed Security / SOC Services (Include Supplier, Product Name, Start Date, Expiry Date, Annual spend 2025/2026 [£], Additional notes [including any framework used])
 DEFINITION: The outsourcing of security monitoring and management to a third-party expert. A Security Operations Center (SOC) is a centralised function (internal or outsourced) responsible for continuous monitoring, threat analysis, and managing security incidents.

6. Please provide the record from the organisation’s Contract Register or equivalent procurement log entry pertaining to the current contract for your current Vulnerability & Compliance Management service (Include Supplier, Product Name, Start Date, Expiry Date, Annual spend 2025/2026 [£], Additional notes [including any framework used])
 DEFINITION: The continuous, cyclical practice of identifying, classifying, prioritising, remediating, and mitigating software weaknesses (vulnerabilities). Compliance Management ensures that security practices adhere to specific internal policies, regulatory requirements (like GDPR), and industry standards.

Yours faithfully,

Adults with Learning Disabilities

Finance, MH Services

Dear Sir/Madam,

Under the Freedom of Information Act, I am requesting information regarding supported living and residential care services for adults with a primary support need of learning disabilities (LD).

Long term care is provided to clients on an ongoing basis and has been allocated on the basis of eligibility criteria / policies (i.e. an assessment of need has taken place) and are subject to regular review. Please refer to the following link for further clarification, if needed (https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-collections/social-care-collection-materials-2024/salt-data-return-2023-2024-guidance/lts001a).

Supported living may also be called Supported accommodation or Supported housing and is a housing scheme where housing, support and care services are provided to help people with disabilities live as independently as possible in the community.

Total placements is the total number of active funded placements in that period, included those carried over from previous years.

New placements are those newly commissioned in that period only, ie not carried over from a previous year.

Please respond using the attached excel template.

For financial year FY26, please provide the full year figure as at the date of your response. For financial year FY27, please provide a forecast or budgeted number of placements if available.

1. Residential Care: Please provide the total number of adults (aged 18-64) with a primary support need of LD in long-term residential care funded by the TRUST, in the following periods, broken down by the following weekly fee bands: £3,000 to £4,999 per week; £5,000 to £6,999 per week; £7,000 or more per week
•Financial year 2021/22 (FY22)
•Financial year 2022/23 (FY23)
•Financial year 2023/24 (FY24)
•Financial year 2024/25 (FY25)
•Financial year 2025/26 (FY26) – Year to Date
•Financial year 2026/27 (FY27) – budgeted / forecast

2. Residential Care: Please provide the number of new placements made for adults (aged 18-64) with a primary support need of LD in long-term residential care funded by the TRUST in the following periods, broken down by the same weekly fee bands: £3,000 to £4,999 per week; £5,000 to £6,999 per week; £7,000 or more per week
•Financial year 2021/22 (FY22)
•Financial year 2022/23 (FY23)
•Financial year 2023/24 (FY24)
•Financial year 2024/25 (FY25)
•Financial year 2025/26 (FY26) – Year to Date
•Financial year 2026/27 (FY27) – budgeted / forecast

3. Supported Living: Please provide the total number of adults (aged 18-64) with a primary support need of LD in long-term supported living funded by the TRUST, in the following periods, broken down by the following weekly fee bands: £3,000 to £4,999 per week; £5,000 to £6,999 per week; £7,000 or more per week
•Financial year 2021/22 (FY22)
•Financial year 2022/23 (FY23)
•Financial year 2023/24 (FY24)
•Financial year 2024/25 (FY25)
•Financial year 2025/26 (FY26) – Year to Date
•Financial year 2026/27 (FY27) – budgeted / forecast

4. Supported Living: Please provide the number of new placements made for adults (aged 18-64) with a primary support need of LD in long-term supported living funded by the TRUST in the following periods, broken down by the same weekly fee bands: £3,000 to £4,999 per week; £5,000 to £6,999 per week; £7,000 or more per week
•Financial year 2021/22 (FY22)
•Financial year 2022/23 (FY23)
•Financial year 2023/24 (FY24)
•Financial year 2024/25 (FY25)
•Financial year 2025/26 (FY26) – Year to Date
•Financial year 2026/27 (FY27) – budgeted / forecast

Please do let me know if there is any clarity that I can provide.

Kind regards,

Print Equipment

Dear Gloucestershire Health & Care NHS Foundation Trust

Please answer the following questions regarding your print equipment set up under Freedom of Information Act 2000 (FOIA)

1. Number of Multi-functional devices / photocopiers at the Trust?

2. Name of current supplier (the incumbent)?

3. When did the contract start?

4. When is it due to end?

5. Details of any extension options beyond above date (Q4)?

6. If contract has ended, when do you intend to re-tender this arrangement?

7. Route to market used – open tender of framework. If framework, which one?

8. Number of single function printers – in addition to above MFD count?

9. Is there a services agreement that covers above (Q8)?

10. Does the Trust have a Print Room?

11. If yes, please advise (a) name of supplier (b) number of devices (c) contract end date (d) details of any extension options?

12. Who at the Trust looks after this contract?

I would be grateful if you would acknowledge receipt of this request and I look forward to receiving your full response within 20 working days.

With kind regards.

End of Life IT Equipment

Dear Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information Act 2000, please provide the following recorded information held by your organisation regarding assurance processes for software based data erasure of end of life IT equipment.

For clarity, this request relates specifically to the erasure of storage media associated with end of life hardware such as laptops, desktops, servers, storage arrays, or other data bearing IT equipment. It does not relate to operational deletion of data within live systems, routine account management, or DSP Toolkit self assessment processes.

Physical destruction methods such as shredding, crushing, degaussing, or disintegration are outside the scope of this request. This request concerns software based erasure only.

This request seeks to distinguish between confirmation that an erasure process was carried out and recorded evidence demonstrating that the final data state of a specific storage device is irrecoverable. I am not seeking technical configuration detail or security sensitive information, only the recorded assurance basis relied upon when concluding that personal data has been rendered irrecoverable.

Please confirm:

1) Whether your organisation’s policies, contractual terms, or internal procedures require an explicit outcome based warranty or guarantee that personal data on a specific storage device has been rendered irrecoverable as a final data state following software based erasure.

2) Where software based erasure of storage media is undertaken internally, what recorded evidential assurance is relied upon to conclude that the final data state of the specific storage device is irrecoverable, as distinct from confirmation that an erasure process was executed.

3) Where software based erasure is undertaken by a third party provider:

a. Do the certificates or contractual documents held constitute an explicit outcome based warranty or guarantee of irrecoverability for each specific storage device processed?

b. Beyond reliance on supplier accreditation or recognised standards including but not limited to ADISA certification, ISO accreditation, NIST alignment, HMG IA standards, NHS Digital guidance, or Data Security and Protection Toolkit assertions, and beyond confirmation that a wiping process was completed, does the organisation hold any recorded, device specific documentation evidencing independent verification, testing, or validation that the data on the storage media has been rendered irrecoverable in practice?

4) If no explicit outcome based warranty or device specific outcome evidence is held beyond certification, accreditation, or confirmation of process completion, please confirm what recorded form of evidential assurance is relied upon when concluding that personal data has been rendered irrecoverable.

Yours faithfully,

Technology Suppliers/Products/Contract Date

Contracts

Dear FOI Team,

I am writing under the Freedom of Information Act 2000 to request information about several systems and services in use at the Trust.

My inquiries are as follows:
Technology Group Supplier Product Contract Ending Date
Electronic patient record ? ? ?
Patient administration system ? ? ?
Electronic prescribing and medicines administration ? ? ?
Maternity information system ? ? ?
Diagnostic imaging information system ? ? ?
Electronic document management system ? ? ?
Laboratory information management system ? ? ?
Cyber security services ? ? ?
Bed management system ? ? ?
Clinical decision support system ? ? ?
Hospital pharmacy system ? ? ?
Population health management system ? ? ?
Hospital discharge system ? ? ?
Theatre scheduling system ? ? ?
Clinical communications system ? ? ?
Remote consultation system provider ? ? ?
Advice and guidance system provider ? ? ?
Virtual ward and remote monitoring system provider ? ? ?
Barcode and scanning technology system provider ? ? ?
Cloud provider ? ? ?
Computer hardware provider ? ? ?
Financial management system ? ? ?
HR/workforce management system ? ? ?
Payroll system ? ? ?
Robotic process automation system ? ? ?
Staff rostering system ? ? ?
Supply chain and inventory management system ? ? ?
Patient engagement portal ? ? ?
Trust Engines ? ? ?
Blood tracking ? ? ?
Critical care systems ? ? ?
Diagnostic reporting ? ? ?
Mental Health Talking Therapy digital tools ? ? ?
Patient communication system ? ? ?
Pathology systems ? ? ?
Pathology PACs ? ? ?
Picture Archiving and Communication Systems ? ? ?
Radiology Information Systems ? ? ?
AI workflow assistants ? ? ?
Business Intelligence tools ? ? ?
Call handling automation systems ? ? ?
Patient care scheduling tools ? ? ?

Please note: In relation to cyber security, we are asking for the name of your main cyber security provider. We do not need to know the software or sub-contractors used.

Clarification on ‘N/A’ Responses:

• Please enter ‘No System Installed’ if your trust does not have such a system.
• Please enter ‘No system needed’ if your trust does not have a department or service which requires such a system.

Clarification on Contract expiry date:

• If the contract expires in the next 6 months, please state if the trust plans to renew, re-procure or take any other action.
• If the contact is on a rolling basis, Please enter ‘Rolling’.

Additionally, could you please fill in the missing product names and revised contract expiry dates?

Locum AHP/HSS – Staffing/Spend

Finance, Nursing & Agency Nursing

Good Morning,
Please can you provide the below information:
From 1st January 2026 to 31st March 2026 please provide a breakdown of:
• Total trust spend with framework agencies for locum AHP/HSS staffing.
Please provide a further breakdown for locum AHP/HSS staffing by:
• Spend per band
• Spend per specialty
• Spend per agency name
In the period 1st January 2026 to 31st March 2026 please provide a breakdown of:
• Total trust spend with off-framework agencies for locum AHP/HSS staffing.
Please provide a further breakdown for locum AHP/HSS staffing by:
• Spend per band
• Spend per specialty
• Spend per agency name
In the period 1st January 2026 to 31st March 2026 please provide a breakdown of:
• Total trust spend with the internal trust bank or associated external provider for locum AHP/HSS staffing
Please provide a further breakdown for locum AHP/HSS staffing by:
• Spend per grade
• Spend per specialty
• Spend per internal or associated external provider
Please confirm your allocated budget for agency locum AHP/HSS staffing for the period 1st January 2026 to 31st March 2026
Please confirm the framework you utilise for AHP/HSS agency staff.
Appreciate your help with this request in advance.
Kind regards,

Medical / Surgical Equipment

Finance, Medical Equipment, Procurement

Hello,

This is a Freedom of Information request regarding the procurement of items.

For the past three years for which full data is available, could you please provide procurement data including cost and number of units for the following items purchased by the Trust:

1. Scissors, including surgical and disposable and single-use versions.

2. Forceps, including artery or tissue forceps.

3. Surgical clamps.

4. Basic hollowware, including gallipots, kidney dishes, instrument trays and bowls.

5. Single-use tourniquets.

6. Harmonic shears.

For each item category, please provide for each year:

a) Total number of units procured
b) Total spend (£)
c) Where recorded in procurement systems, whether the items were designated as single-use/disposable.

Additionally, for the same three financial years, please provide:

Total number of the following mobility aids procured: Crutches Walking frames Walking sticks

And for each of the above mobility aids:

a) Total annual spend (£)
b) If recorded centrally, the number of units refurbished or reissued through reuse schemes

If providing the above data in full would exceed the appropriate cost limit under Section 12 of the Act, please provide the data for the most recent year only. If any clarification is required, please let me know. Yours faithfully,

ECT information package

GHNHSFT - Redirect

Dear Sir/Madam,

I am writing for an FOI request regarding ECT treatments.

I would like to know the following:

1. What information (verbal, written) is given to patients prior to receiving ECT? Please provide a copy if a digital version exists, or otherwise list what information is provided regarding the procedure and potential side effects.
2. What is the level of consent and procedure prior to initiating ECT procedures? (e.g. is patient consent always required, or can it be overridden by a medical expert? Is there a standard procedure or a case-by-case basis?)

I look forward to your response in due time.

Kind regards,

Surgical Treatment of Breast Cancer

GHNHSFT - Redirect

Dear FOI Team,

I am writing to request information under the Freedom of Information Act regarding the use of wire free localisation devices within your organisation.

Please complete the attached table with the relevant information which you hold.

I understand the statutory deadline for FOI responses is 20 working days.I would be grateful to receive the information electronically as presented below.

Kind regards,
Ms. Ashleigh James (BSc, MBA)

These questions are in relation to the surgical treatment of Breast Cancer, using wire free localisation devices. These questions DO NOT relate to Biopsy clips or markers.

# Question Text Response Value (£) Quantity Date
1 Which department is currently responsible for the delivery of wire-free localisation devices? N/A N/A N/A
2 Who is the clinical lead for your organisations’ department? N/A N/A N/A
3 Is this department part of a wider clinical delivery network? i.e. West Midlands Cancer Alliance N/A N/A N/A
4 What system(s) are you currently using for wire-free localisation? N/A N/A N/A
5 Which supplier(s) was the current contract awarded to? N/A N/A N/A
6 When was the contract(s) awarded? N/A N/A N/A
7 How long is the contract(s) awarded for? Please include any extension options. N/A N/A N/A
8 Please provide the Contract Award Notice reference for the contract(s) listed in Question 5. N/A N/A N/A
9 What was the awarded value of the current contract(s)? N/A N/A N/A
10 Please confirm the procurement award route and market engagement undertaken prior to award, referencing any linked notices to Question 8. N/A N/A N/A
11 How many patients have been treated to date under the current contract(s)? N/A N/A N/A
12 How many systems are in operation as part of the current contract(s)? N/A N/A N/A
13 How many seeds or markers have been used as part of the current contract(s)? N/A N/A N/A
14 When is the current contract(s) due for retender? N/A N/A N/A
15 Who will lead on the new procurement process from a) Clinical Dept; b) Procurement N/A N/A N/A
16 Are there any other organisations who are named beneficiaries of this contract(s)? N/A N/A N/A

Ophthalmology – HA Eye Drops

GHNHSFT - Redirect

Dear Sir / Madam,

Under the Freedom of Information Act, please can you answer the following questions:

1. How much did your organisation spend on Sodium Hyaluronate eye drop formulations between the period of 01/01/2025 to 31/12/2025?

2. Between the period 01/01/2025 to 31/12/2025, which brand(s) of Sodium Hyaluronate eye drop formulations did you use?
To make your research easier, I have listed all commonly used brands which you can cross reference:

• Blink Intensive Tears
• Lacrifresh
• Artelac Rebalance
• Oxyal
• Xailin HA
• Optive Fusion
• Hyabak
• Hydramed
• Evolve HA
• Vismed Multi
• Clinitas Multi
• Eye Logic
• Euphrasia
• Biotrue
• Vismed Gel Multi
• Hysoothe
• Optrex Night Restore Gel
• Hy-Opti
• Hylo-Tear
• Murine Professional
• Hylo-Forte
• Hycosan Fresh
• Hylo Care
• Hycosan

3. How many units of each brand did you use?

Please respond to this email address.

Thanks and I look forward to hearing from you soon.

Mental Health Service for Young People

CAMHS Services, CAMHS/CYPS, MH Services

To whom it may concern,
Under the Freedom of Information Act I would like to request the following information.

Does your NHS trust provide any mental health services for under 18 year olds (e.g. CAMHS)?

If you do not, please reply stating that you do not provide mental health services for under 18 year olds and none of the other questions of this FOI are required as they are not relevant.

If you do provide mental health services for under 18 year olds:

• What is the age brackets for the mental health services for young people before they move to adult services (for example 0-18 year olds or 0-25 years old)?
• What do you call this service (for example Child and Adolescent Mental Health Services (CAMHS) or if there is a specific name you use)?
• What methods of referral do you accept (for example- referrals from GPs/schools)?
• Are self referrals an option? If so what are the requirements (e.g. minimum age)?
• What is your method of advising patients of appointments (e.g. text/post)?

I would also like to request a blank document of the following forms:
• The form used by GPs/schools to refer a young person
• The form used if a young person is referring themselves
• Any forms that are provided at the first appointment for the young person/parent to fill out in regards to contact information, preferences of methods of contact, who is attending the appointments etc
• Any relevant forms to indicate who is attending the appointment/aware of the referral (young person/their guardian/both) and which of the two should be contacted and if there is a preference of contact method

Incidents of Sexual Violence

Corporate Governance

Dear Sir,

FOI request: Governance related to sexual offending at the trust

1) Please disclose by each of the following years, the total number each year of incidents of sexual violence (including sexual assault and rape) reported by the trust to the Care Quality Commission:

2021/22
2022/23
2023/24
2024/25
2025/26 YTD

3) It has been reported by the media that a patient was raped whilst under the trust’s care in the last financial year.

Please confirm if this is the case.

Please advise if and when the CQC was informed of this serious incident

Please advise:

a) if this incident took place on trust premises
b) whether the patient was under inpatient care
c) if the patient was detained under the Mental Health Act

Please advise what review if any has been undertaken by the trust, and what learning and Safeguarding improvements have been made since the incident.

4) Please advise if the trust undertakes any benchmarking to compare its rates of sexual violence against other comparator trusts, the results of any such benchmarking and any action plans arising.

Yours,

Digital Maturity & Digital processes

To Whom It May Concern,

Please find below FOI request.

Could I please request that when responding, if the name of your organisation is not in your email signature that additionally this is provided.

1. What is the name of your organisation

2. Within which Nation do you report (England, Scotland, Wales, Northern Ireland)

3. To which ICS / ICB (or alternative) do you report / belong? (if this is in the process of changing please give the name of the new organisation as you will be of 1 May 2026)

4. Does your senior leadership team have live access to updates regarding the Trust corporate plan?

5. Are you able to provide live reporting regarding shared projects / risks to your local ICB / ICS / appropriate alternative body?

6. What is your latest NHS Digital Maturity Score?

7. What software do you use for the management of Projects?

8. Who is responsible for the overall management / reporting of projects?

9. What software do you use for the management of corporate risks?

10. Who is responsible for overall management management / reporting of corporate risks to the board?

11.Is any part of the organisation currently using Microsoft project Online?

12. If yes to the previous questions, which teams / departments?

13. What is your organisations policy in regards to AI & AI Solutions

If you would prefer to answer using a Microsoft Form, that can be done so using this link.

Kind Regards

Adult Gynaecology services

Contracts

Hello,

I am submitting this request, on behalf of myself, under the Freedom of Information Act and the Code of Practice on Openness in the NHS.

Please confirm the Trust holds the following data and where it is held; please provide the data as requested. I would like to receive this information by email.

1. Does the trust offer gynaecology services (covering any form of Obstetrics or gynaecology services and including those delivered by another provider)?

If yes:

2. For each service and/or contract identified in the answer to #1, please provide the following schedules as included in the contract the Trust holds:

Schedule 2A or equivalent: Service Specification that describes the service (whether standalone or integrated in a broader Service Specification)
Schedule 3A, 3B or 3C or equivalents: Describing national currencies and any local prices that apply to the services

Please provide any embedded files in a format that can be opened.

Adult Cardiometabolic services

Contracts

Hello,

I am submitting this request, on behalf of myself, under the Freedom of Information Act and the Code of Practice on Openness in the NHS.

Please confirm the Trust holds the following data and where it is held; please provide the data as requested. I would like to receive this information by email.

1. Does the trust offer cardiometabolic services (covering any form of cardiometabolic, cardiology, cardiovascular services or a community service that covers cardiology care including those delivered by another provider)?

If yes:

2. For each service and/or contract identified in the answer to #1, please provide the following schedules as included in the contract the Trust holds:

Please provide any embedded files in a format that can be opened.

NHS Medical Equipment Tracking

Estates, Medical Equipment

1. Current Use of Asset Tracking
a) Does your organisation use any system to track the location of medical equipment?
(Yes / No)
If “No” go to section 4.
b) If yes, which of the following methods are used to track equipment? (please select all that apply)
• Fixed scanners or handheld scanners that detect tagged equipment automatically (e.g. radio-frequency or similar technologies)
• Tags or sensors attached to equipment that provide location updates within buildings (e.g. via Bluetooth or similar signals)
• Scanning barcodes or QR codes on equipment using mobile devices
• Location tracking using GPS (e.g. for equipment used in the community)
• Manual recording of equipment location (e.g. spreadsheets, paper records, or asset registers)
• Other (please specify)
c) If known, please provide the name(s) of any supplier(s) used.
________________________________________
2. Scope of Tracking
a) Does tracking cover:
• Acute settings only
• Acute and community settings
• Community settings only
b) Approximately how many assets are tracked?
• <1,000 • 1,000–5,000 • 5,000–10,000 • 10,000+ ________________________________________ 3. Operational Challenges Does your organisation experience any of the following? (please select all that apply) • Equipment not available when needed • Time spent by staff searching for equipment • Difficulty locating devices for maintenance or compliance • None of the above ________________________________________ 4. Evaluation and Future Plans a) Has your organisation produced any internal report or evaluation relating to asset tracking systems? (Yes / No) b) Are there plans to review or expand asset tracking capabilities within the next 24 months? (Yes / No / Unknown) ________________________________________

Nursing Spend

Finance, Nursing & Agency Nursing

Good afternoon,
Please can you provide the below information:
In the period 1st January 2026 to 31st March 2026 please provide a breakdown of:
• Total trust spend with framework agencies for locum nurses
Please provide a further breakdown for locum nurses by:
• Spend per band
• Spend per specialty
• Spend per agency name
In the period 1st January 2026 to 31st March 2026 please provide a breakdown of:
• Total trust spend with off framework agencies for locum nurses
Please provide a further breakdown for locum nurses by:
• Spend per band
• Spend per specialty
• Spend per agency name
In the period 1st January 2026 to 31st March 2026 please provide a breakdown of:
• Total trust spend with the internal trust bank or associated external provider for locum nurses
Please provide a further breakdown for locum nurses by:
• Spend per band
• Spend per specialty
• Spend per agency name
Please confirm the total number of nursing shifts booked during this period for all agency nursing only, no bank staff nursing to be included (1st January 2026 to 31st March 2026)
Please confirm the total number of nursing shifts booked above NHSE capped rates during this period for all agency nursing only, no bank staff nursing to be included (1st January 2026 to 31st March 2026)
Please confirm the framework you utilise for nursing agency staff.
Kind regards

NHS Chaperone Policies, Training and Reporting

Organisation

Dear Gloucestershire Health and Care NHS Foundation Trust,

Please provide the following information on NHS chaperone policies, training and reporting:

1) Current chaperone policy or policies relating the use of formal and informal chaperones.

2) Associated procedures & guidelines including:
a) Guidance on how the offer, acceptance, or refusal of a chaperone must be recorded in patient notes.
b) Guidance on how the sex of the chaperone is recorded.

3) If your policy/procedures/guidelines have been withdrawn, please provide:
a) the most recent version.
b) the date it was placed under review or withdrawn.
c) the communications with staff when it was put under review or withdrawn.
d) the timetable for development and approval of any replacement policy
e) details of internal and external consultation lists.

4) If not included in the policy/procedures/guidelines, please also disclose:
a) training and competency standards for staff acting as formal chaperones.
b) training description and provision for chaperones (eg online, in person, what organisations delivers the training and outline).

5) Audit reports, quality assurance reviews, compliance monitoring, and management and/or board reports relating to chaperoning 2024 to date.

6) Related equality impact assessments (EIAs) if separate

7) Datix reports:
a) Number of Datix reports raised related to chaperoning in 2024, 2025 and 2026 Jan & Feb, by sex of patient and chaperone & definition of sex field in Datix.
b) If you record this data by gender, please disclose the Number of Datix reports raised related to chaperoning in 2024, 2025 and 2026 Jan & Feb, by gender of patient and chaperone and definition of gender field in Datix.

8) Concerns:
a) Number of concerns raised by chaperones, if not recorded via Datix, in 2024, 2025 and 2026 Jan & Feb, by sex of patient and chaperone & definition of sex field.
b) If you record this data by gender, please disclose the number of concerns raised by chaperones in 2024, 2025 and 2026 Jan & Feb, by gender of patient and chaperone and definition of gender field.

9) Complaints:
a) Number of complaints raised related to chaperoning in 2024, 2025 and 2026 Jan & Feb, by sex of patient and chaperone & definition of sex field in your complaints system.
b) If you record this data by gender, please disclose the number of complaints raised related to chaperoning in 2024, 2025 and 2026 Jan & Feb, by gender of patient and chaperone and definition of gender field in your complaints system.
c) Number of Freedom to Speak Up reports related to chaperones in 2024, 2025 and 2026 Jan & Feb by sex of the reporter.
d) If you record this data by gender, please disclose the number of cFTSU reports related to chaperoning in 2024, 2025 and 2026 Jan & Feb, by gender of the reporter.

Redactions
If it is necessary for any reason to redact any information, please redact the minimum necessary and send me the rest of the material, explaining the legal grounds for each redaction.

Accessibility:
Please provide the information by email in either Adobe Portable Document Format (pdf), Microsoft Word .docx or .doc format, Microsoft Excel .xlsx or .xls format, Microsoft Powerpoint .pptx or .ppt format or, if appropriate, in the body of the email. Please include all email attachments and enclosures. Information supplied in pdf format should be text searchable using Adobe Reader. All metadata for every original file held (created and modified dates, author, etc) should be included. All responses and documents must permit printing, search and content copying and must not be protected by a password.

If this request needs refining to make it possible for you to comply without incurring excessive costs, please consider ways in which you can help me to refine my request so you answer my request without exceeding the appropriate limit. Please let me know asap so we can reframe the request to enable you to respond within 20 working days within the cost limit.

Please confirm reciept of this request.

Management System for Agency Staff

Contracts, Nursing & Agency Nursing

Under the FOI act please can you confirm the following:

Please confirm if you operate a vendor management system for agency staff such as an MSP/neutral vendor/master vendor etc.
If so, please can you name the below:
-Company name
-Contract start and end date
-Framework utilised
-Healthcare specialty used for, EG Doctors/Nursing/AHP/HSS/NMNC
-Do you utilise a direct engagement model and the name of the model, eg Tempre/Own DE model etc

Please confirm if you operate a vendor management system for bank staff.
If so, please can you name the below:
-Company name
-Contract start and end date
-Framework utilised
-Healthcare specialty used for, EG Doctors/Nursing/AHP/HSS/NMNC

Hospital Wards

Corporate Governance

Dear Gloucestershire Health and Care NHS Foundation Trust,

i. The name of each ward. e.g Ward 2
ii. The location of each ward. e.g Stroud General Hospital iii. The speciality of each ward. e.g Cardiology iv. The number of beds on each ward.

Yours faithfully,

Retained Foreign Objects Post-Procedure

GHNHSFT - Redirect

Dear NHS Trust

1. How many incidents of a retained foreign object post-procedure were logged by your Trust in the past three years? (2022/23, 2023/24, 2024/25)

1a) Please break down this information by year (as outlined above).

1b) If possible, please break down this information by retained object (including but not limited to the examples listed above).

NB Please interpret ‘retained foreign object post-procedure’ as objects accidentally left inside patients following surgical procedures – e.g. guide wires, mouth props, surgical instruments, needles, vaginal swabs, throat packs, clips etc.

Many thanks

Surgical Procedure – Stroud General Hospital

Misc

I wish to find out whether surgical procedures to resect bowel, breast or prostate cancer are performed at Stroud General Hospital please.

Mental Health Clinical Activity Data

Clinical Activity Data, MH Services

Dear Freedom of Information Officer,
I am writing to request information under the Freedom of Information Act regarding your mental health trust. Please could you provide the following details:
1. The current total number of staff employed by the mental health trust.
2. The number of inpatient episodes and Outpatient Appointments (OPA’s) recorded by the trust for each of the past three years, broken down annually.
3. The number of referrals made to your organisation for each of the past three years, broken down annually.
4. The organisational structure of your data quality staff, including the number of staff in each role and their respective pay bands.
If possible, I would appreciate the information in an electronic format.
Thank you for your assistance. I look forward to your response within the statutory timeframe.
Yours sincerely,

Uniform, Infection Control & Surgical Scrubbing Policies

ESR/Workforce, HR

Dear Freedom of Information Officer,

I am writing to make a request under the Freedom of Information Act 2000 (or Freedom of Information (Scotland) Act 2002 where applicable) for the following information:

1. Your current Uniform and Dress Code Policy (including any appendices)
2. Your current infection prevention and Control Policy / guidance specifically covering:
Bare below the elbow requirements ,
permitted jewellery in clinical areas – eg wedding rings
Any accommodations for articles of religious faith (hijab, niqab, kippah, kara, kirpan, crucifix, turban etc.)
3. Any specific dress code guidance for
general clinical areas
high infection risk areas like ICU,ITU, Isolation
any dress policy pertaining to surgical/theatre environments and any scrubbing protocols
4. Any Equality impact assessment conducted in relation to the above policies
5. The date each policy was last reviewed and scheduled next review date

If any information is already publicly available, please direct me to the URL.
If this request is too broad or unclear, I would be happy to discuss how it might be refined

I understand you are required to respond within 20 working days. And I look forward to hearing your response

Thankyou for your assistance

Pay Protection

ESR/Workforce, HR

Dear FOI Team, I would like to request the following information under the Freedom of Information Act 2000: 1. A copy of your current Pay Protection Policy (or equivalent document outlining the Trust’s approach to protecting earnings following redeployment, downbanding, or reduction in contracted hours). If the policy is part of a wider document (e.g. organisational change, redeployment, HR, or workforce policies), please provide the relevant section or the full document. I would prefer the information in electronic format. Many thanks, Kind regards

Eating Disorder Service

MH Services, What Do They Know

I would like to request from SEDS and The Sussex Family Eating Disorder Service, for each of the calendar years 2022, 2023, 2024 and 2025 (to date, if full-year data is not yet available):

1. The total number of referrals and admissions to the Eating Disorders Services at Brownhill.

Where possible, please:

• Provide the data broken down by year.
• Provide a separate figure for patients admitted with a primary diagnosis of Anorexia Nervosa.

If diagnostic breakdowns are recorded using ICD-10 or ICD-11 codes, please include the codes:

F50.01: Anorexia nervosa, restricting type.
F50.02: Anorexia nervosa, binge eating/purging type.
F50.00: Anorexia nervosa, unspecified.

If a breakdown by diagnosis is not readily available within the cost limit, please provide the aggregate totals only.

If the Trust does not hold some or all of this information, please confirm this and direct me to the appropriate body where possible.

I would prefer to receive the information in electronic format (Excel or CSV).

CAMHS Patient Activity

Clinical Activity Data

Dear Sir/Madam,

I am writing to make a FOI request. Please supply the requested information below:-

1. Please provide, where this information is held in a reportable or centrally recorded format, the number of CAMHS patients under 18 who were prescribed psychotropic medication prior to a formal psychiatric diagnosis being recorded, in each of the last five financial years.
2. Please provide the Trust’s written policy or clinical governance guidance governing circumstances in which CAMHS clinicians may exclude a parent holding parental responsibility from communication about their child’s assessment, treatment or care;
3. Please provide, where this information is held in a reportable or centrally recorded format, the number of CAMHS patients under 18 who were prescribed psychotropic medication following their first CAMHS appointment, in each of the last five financial years.
4. Please provide any Trust policy, guidance, or training material relating to how CAMHS clinicians should proceed where parents holding parental responsibility disagree about treatment decisions;
5. Please provide the average and median number of CAMHS clinical appointments attended by patients before psychotropic medication is first prescribed, for each of the last five financial years;
6. Please provide any Trust policy, guidance, or training materials used within CAMHS which address how clinicians should respond where a parent disagrees with or refuses consent to proposed mental health treatment for a child.
7. Please confirm whether the Trust records within its clinical or administrative systems whether all individuals holding parental responsibility were or are informed or consulted prior to treatment decisions being made for CAMHS patients. If such information is recorded, please confirm the fields or mechanisms used to record this information.

If any part of this request is considered to exceed the cost limit under Section 12 of the Freedom of Information Act 2000, please provide advice and assistance under Section 16 to refine the request so that the information may be supplied.

Yours faithfully,

Forced Tranquilisation on MH Patients in Emergency Departments

GHNHSFT - Redirect

Dear Trust FOI team,

Using the Freedom of Information Act 2000, I am writing to request data on the total number of instances of forced tranquilisation for the restraint of mental health patients in emergency departments in your trust each month, from the most recent month you have data for this, to as far back as records go.

All the best,

Patient Safety Incidents

Media

I want to submit an FOI request for:

Please can you confirm:

1 – For years :
2024/25
2023/24
2022/23
2021/22
2020/21
2019/20
How many patient safety incidents met the requirements for the statutory duty of candour?
ANSWER: a number – eg. 10… for each of the 6 years requested.

2 – Across your surgical teams, do you have any surgeons that are currently internally suspended from carrying out their duties at your Trust?
ANSWER: yes OR no

If you do have surgeons that are currently suspended, did you inform the GMC or is it an internal matter?
ANSWER: GMC involved OR handled internally

If you do have surgeons that are currently suspended, did the RCS provide a report/advice/support in any capacity.
ANSWER: yes OR no

If answers could be provided asap that would be greatly appreciated.

Thank you,

Retained Foreign Objects Post-Procedure

GHNHSFT - Redirect

Dear NHS Trust

I am requesting this information under the Freedom of Information Act.

Could you please provide data in response to the following questions:

1. How many incidents of a retained foreign object post-procedure were logged by your Trust in the past three years? (2022/23, 2023/24, 2024/25)
NB Please interpret ‘retained foreign object post-procedure’ as objects accidentally left inside patients following surgical procedures – e.g. guide wires, mouth props, surgical instruments, needles, vaginal swabs, throat packs, clips etc.
1a) Please break down this information by year (as outlined above).
1b) If possible, please break down this information by retained object (including but not limited to the examples listed above).
2. How many claims have been made against the Trust in relation to retained foreign objects post-procedure in the past three years? (2022/23, 2023/24, 2024/25)
2a) Please break down this information by year (as outlined above).
3. What is the total sum paid out in claims made against the Trust in relation to retained foreign objects post-procedure in the past three years? (2022/23, 2023/24, 2024/25)
3a) Please break down this information by year (as outlined above).

3b) If possible, please provide the highest fee paid out in claims made against the Trust in relation to retained foreign objects post-procedure for each of the years outlined above.

« Older Entries

Next Entries »

Responses

Get in touch with us

Better Care Together